candesartan cilexetil and atorvastatin

candesartan cilexetil has been researched along with atorvastatin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF1
Hashimoto, T; Inayama, Y; Iwatsubo, K; Kihara, M; Kokuho, T; Kuji, T; Oshikawa, J; Tamura, K; Tanaka, K; Toya, Y; Umemura, S; Yabana, M; Yanagi, M; Yoshida, S1

Reviews

1 review(s) available for candesartan cilexetil and atorvastatin

ArticleYear
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
    European journal of medicinal chemistry, 2022, Jul-05, Volume: 237

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells

2022

Other Studies

2 other study(ies) available for candesartan cilexetil and atorvastatin

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Behçet's disease complicated by IgA nephropathy with nephrotic syndrome.
    Clinical and experimental nephrology, 2008, Volume: 12, Issue:3

    Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Atorvastatin; Behcet Syndrome; Benzimidazoles; Biphenyl Compounds; Dilazep; Drug Therapy, Combination; Female; Glomerulonephritis, IGA; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Nephrotic Syndrome; Pyrroles; Tetrazoles; Vasodilator Agents

2008